Use and Misuse of GLP-1 Receptor Agonists Among People With Eating Disorders
This cross-sectional study evaluates the prevalence of glucagon-like peptide-1 (GLP-1) receptor agonist use and misuse among people with eating disorders in the US.
Authors
- Banrida Wahlang (ORCID: https://orcid.org/0000-0002-4356-1743)
- Jon E. Zibbell (ORCID: https://orcid.org/0000-0001-9373-7818)
- Sathya S. Krishnasamy
- Nicholas C. Peiper
- Cheri A. Levinson
- Andrew S. LaJoie
Institutions
- University of Louisville (US)
- ICF International (United States) (US)
Publication Details
- Journal
- JAMA Psychiatry
- Published
- 2026-06-24
- DOI
- https://doi.org/10.1001/jamapsychiatry.2026.1716
- Primary Topic
- Eating Disorders and Behaviors
- Type
- article
- Field-Weighted Citation Impact
- 0.00